Latozinemab Gets Breakthrough Therapy Status for Frontotemporal Dementia
Frontotemporal dementia is an early-onset form of dementia that affects behavior, language, and movement.
Source: empr.com
Page 25 - Breakthrough Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Breakthrough Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Breakthrough Therapy Today - Breaking & Trending Today
Madrigal Pharmaceuticals Announces Publication of the Phase 3 MAESTRO-NASH Trial of Resmetirom in the New England Journal of Medicine
Resmetirom is the first investigational medicine for NASH to achieve fibrosis improvement and NASH resolution primary endpoints in a Phase 3 trial...
Source: businessinsider.com
Vertex Pharmaceuticals Stock Is Approaching a Huge Catalyst, But Is It a Buy?
Its pain medicine isn't precisely what it hoped for, but it could still sell.
Source: fool.com
Law Enforcement Data Indicate Growing Psilocybin Use
A dramatic increase in law enforcement seizures of psilocybin-containing "magic mushrooms" likely indicates growing use and public acceptance of the psychedelic.
Source: medscape.com
Ensysce Biosciences Selected to Present at American Association of ...
Ensysce Biosciences Selected to Present at American Association of ...
Source: pr-inside.com